Edition:
United States

CVS Health Corp (CVS)

CVS on New York Consolidated

52.77USD
24 Apr 2019
Change (% chg)

$-0.19 (-0.36%)
Prev Close
$52.96
Open
$52.99
Day's High
$53.04
Day's Low
$52.68
Volume
445,608
Avg. Vol
12,967,263
52-wk High
$82.15
52-wk Low
$51.77

Latest Key Developments (Source: Significant Developments)

CVS Health Says CEO Larry Merlo's FY 2018 Total Compensation Was $21.9 Mln
Friday, 5 Apr 2019 05:48pm EDT 

April 5 (Reuters) - CVS Health Corp ::CVS HEALTH SAYS CEO LARRY MERLO'S FY 2018 TOTAL COMPENSATION WAS $21.9 MILLION VERSUS $12.3 MILLION IN FY 2017 - SEC FILING.CVS HEALTH CORP SAYS COO JONATHAN ROBERTS' FY 2018 TOTAL COMPENSATION WAS $16.1 MILLION VERSUS $6.9 MILLION IN FY 2017.CVS HEALTH CORP SAYS RATIO OF CEO ANNUAL COMPENSATION TO MEDIAN EMPLOYEE FOR 2018 IS 618-TO-1.  Full Article

U.S. Senate Finance Committee's Grassley, Wyden Invite 5 PBMS To Drug Pricing Hearing
Tuesday, 12 Mar 2019 06:27pm EDT 

March 12 (Reuters) - U.S. Senate Finance Committee::GRASSLEY, WYDEN INVITE 5 PHARMACY BENEFIT MANAGERS TO DRUG PRICING HEARING ON APRIL 3.COS INVITED INCLUDE CIGNA CORPORATION, CVS CAREMARK & CVS HEALTH CORPORATION, HUMANA INC, OPTUMRX & PRIME THERAPEUTICS.  Full Article

Aetna Enters Into Agreement With Healthy Business Group
Monday, 28 Jan 2019 03:44pm EST 

Jan 28 (Reuters) - Healthy Business Group::AETNA ENTERS INTO AGREEMENT WITH HEALTHY BUSINESS GROUP.HEALTHY BUSINESS GROUP- CO, AETNA ANNOUNCED AGREEMENT THAT OFFERS HBG'S PORTFOLIO OF HEALTH,WELL-BEING SOLUTIONS TO AETNA'S MEMBERS IN NY & NEW JERSEY.  Full Article

Ritzman Pharmacy To Sell Pharmacy Business To Cvs Pharmacy
Monday, 7 Jan 2019 08:09am EST 

Jan 7 (Reuters) - Ritzman Pharmacies Inc::PRESS RELEASE - RITZMAN PHARMACY TO SELL PHARMACY BUSINESS TO CVS PHARMACY.RITZMAN PHARMACY TO SELL PHARMACY BUSINESS TO CVS PHARMACY.RITZMAN PHARMACIES INC - ANNOUNCED THAT IT PLANS TO SELL ITS 20 RETAIL PHARMACIES TO CVS PHARMACY.RITZMAN PHARMACIES - CVS PHARMACY PLANS TO OPERATE IN SAME LOCATIONS WITH SAME STAFF IN AKRON AND BERLIN STORES.  Full Article

Cvs Health Sets Quarterly Dividend Of $0.50Per Share
Thursday, 3 Jan 2019 09:00am EST 

CVS Health Corp ::SETS QUARTERLY DIVIDEND OF $0.50PER SHARE.  Full Article

CVS Health Says Savings From Aetna Transaction May Exceed $750 Mln- Conf. Call
Tuesday, 6 Nov 2018 09:52am EST 

Nov 6 (Reuters) - Cvs Health Corp ::SAYS SAVINGS FROM AETNA TRANSACTION MAY EXCEED $750 MILLION- CONF. CALL.SAYS HAS REACHED AGREEMENT WITH CALIFORNIA STATE REGULATOR ON AETNA DEAL AND IS FINALIZING TERMS.  Full Article

CVS Health Reports Q3 GAAP EPS From Continuing Operations Of $1.36
Tuesday, 6 Nov 2018 06:55am EST 

Nov 6 (Reuters) - CVS Health Corp ::Q3 GAAP EPS FROM CONTINUING OPERATIONS OF $1.36 .CVS HEALTH CORP QTRLY NET REVENUES INCREASED 2.4% TO $47.3 BILLION.CVS HEALTH CORP QTRLY ADJUSTED EPS OF $1.73.CVS HEALTH CORP SEES 2018 GAAP DILUTED EPS FROM CONTINUING OPERATIONS OF $1.40 TO $1.50.CVS HEALTH CORP SEES 2018 ADJUSTED EPS OF $6.98 TO $7.08.CVS HEALTH CORP SEES 2018 CASH FLOW FROM OPERATIONS OF ABOUT $9.0 BILLION; FREE CASH FLOW OF APPROXIMATELY $7.0 BILLION.CONFIRMED FULL YEAR GUIDANCE.CVS HEALTH CORP QTRLY SAME STORE SALES INCREASED 6.7% AND PHARMACY SAME STORE SALES INCREASED 8.7% IN THE QUARTER ENDED SEPT 30, 2018.FRONT STORE SAME STORE SALES INCREASED 0.8% IN THE QUARTER ENDED SEPT 30, 2018, COMPARED TO THE SAME QUARTER OF THE PRIOR YEAR.Q3 GAAP EPS FROM CONTINUING OPERATIONS OF $1.36.REGULATORY APPROVAL PROCESS FOR AETNA DEAL IS PROCEEDING WITHIN TIMEFRAME CONSISTENT WITH EXPECTATIONS.IN Q2 CO HAD $3.9 BILLION GOODWILL IMPAIRMENT CHARGE RELATED TO LTC BUSINESS.  Full Article

Teamsters Local 727 Resumes Negotiations With CVS For A New Collective Bargaining Agreement
Wednesday, 26 Sep 2018 12:27pm EDT 

Sept 26 (Reuters) - TEAMSTERS LOCAL 727 ::TEAMSTERS LOCAL 727 - CVS, TEAMSTERS LOCAL 727 RESUMED NEGOTIATIONS FOR A NEW COLLECTIVE BARGAINING AGREEMENT SEPT. 21.TEAMSTERS LOCAL 727 SAYS IT FILED LABOR PRACTICE CHARGE AGAINST CVS OVER ITS DELAY TO RESPOND THAT IS PENDING WITH NATIONAL LABOR RELATIONS BOARD.  Full Article

Teamsters Local 727 Says Filed An "Unfair Labor Practice" Charge Against CVS
Friday, 7 Sep 2018 03:30pm EDT 

Sept 7 (Reuters) - Teamsters Local 727::TEAMSTERS LOCAL 727 - FILED AN "UNFAIR LABOR PRACTICE" CHARGE AGAINST CVS ON SEPT. 7.TEAMSTERS LOCAL 727 - BARGAINING COMMITTEE AND CVS WILL HOLD THEIR NEXT COLLECTIVE BARGAINING MEETING ON SEPT. 21.  Full Article

CVS Announces Management Team For Combined Co Following Close Of Aetna Acquisition
Wednesday, 6 Jun 2018 08:30am EDT 

June 6 (Reuters) - CVS Health Corp ::CVS HEALTH ANNOUNCES MANAGEMENT TEAM FOR COMBINED COMPANY FOLLOWING CLOSE OF AETNA ACQUISITION TRANSACTION.CVS HEALTH ANNOUNCES MANAGEMENT TEAM FOR COMBINED COMPANY FOLLOWING CLOSE OF AETNA ACQUISITION TRANSACTION.CVS HEALTH CORP - JON ROBERTS WILL CONTINUE TO SERVE AS EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER FOR CVS HEALTH.CVS HEALTH CORP - UNTIL DEAL CLOSE , CVS HEALTH & AETNA WILL CONTINUE TO OPERATE AS 2 SEPARATE COS.CVS HEALTH CORP - RICHARD DI BENEDETTO WILL CONTINUE TO SERVE IN HIS CURRENT POSITION OF PRESIDENT OF AETNA INTERNATIONAL.CVS HEALTH - KAREN S. LYNCH, CURRENTLY PRESIDENT OF AETNA, WILL SERVE AS EXECUTIVE VICE PRESIDENT OF CVS HEALTH AND PRESIDENT FOR AETNA BUSINESS UNIT.CVS HEALTH CORP - AS PART OF TRANSITION OF ORGANIZATIONS, SEVERAL EXECUTIVES FROM BOTH CVS HEALTH & AETNA WILL BE DEPARTING.CVS HEALTH - SHAWN M. GUERTIN, CURRENTLY CFO FOR AETNA, WILL ASSUME POSITION OF EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER FOR CVS HEALTH.CVS HEALTH CORP - DAVID DENTON, WHO CURRENTLY SERVES AS CVS HEALTH'S CHIEF FINANCIAL OFFICER HAS ELECTED TO DEPART COMPANY AT DEAL CLOSE.CVS HEALTH - TRANSACTION WITH AETNA EXPECTED TO CLOSE IN SECOND HALF OF 2018, SUBJECT TO REQUIRED REGULATORY APPROVALS.  Full Article

Photo

U.S. judge expecting CVS merger hearing for May

WASHINGTON A U.S. federal judge reviewing an agreement between the government and CVS Health Corp allowing the pharmacy chain to buy health insurer Aetna indicated on Friday that he wanted to hold a hearing in May to hear from critics of the $69 billion deal.